Paper40733652
A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers.
Fukushima S and 2 others. Vaccines (Basel), 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers. Papers, record 40733652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40733652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 20K10354 | Japan Society for the Promotion of Science | PubMed |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38272044 | Long-term immunity following yellow fever vaccination: a systematic review and meta-analysis. | Lancet Glob Health | 2024 | https://conductscience.org/library/papers/38272044 | PubMed |
| 2 | 38926068 | Duration of post-vaccination immunity to yellow fever in volunteers ten years after a dose-response study - A complementary study. | Vaccine | 2024 | https://conductscience.org/library/papers/38926068 | PubMed |
| 3 | 26360663 | Booster dose after 10 years is recommended following 17DD-YF primary vaccination. | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/26360663 | PubMed |
| 4 | 36702208 | Analysis of cross-reactivity among flaviviruses using sera of patients with dengue showed the importance of neutralization tests with paired serum samples for the correct interpretations of serological test results for dengue. | J Infect Chemother | 2023 | https://conductscience.org/library/papers/36702208 | PubMed |
| 5 | 31298654 | 17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil. | Emerg Infect Dis | 2019 | https://conductscience.org/library/papers/31298654 | PubMed |
| 6 | 26086636 | Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. | MMWR Morb Mortal Wkly Rep | 2015 | https://conductscience.org/library/papers/26086636 | PubMed |
| 7 | 36967285 | Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults. | Vaccine | 2023 | https://conductscience.org/library/papers/36967285 | PubMed |
| 8 | 34401911 | Long-term immunity after a single yellow fever vaccination in travelers vaccinated at 60 years or older: A 10-year follow-up study. | J Travel Med | 2021 | https://conductscience.org/library/papers/34401911 | PubMed |
| 9 | 20463105 | Correlates of protection induced by vaccination. | Clin Vaccine Immunol | 2010 | https://conductscience.org/library/papers/20463105 | PubMed |
| 10 | 39617485 | Long-Term Immunity after Vaccination against Yellow Fever in Korean Travelers. | Jpn J Infect Dis | 2025 | https://conductscience.org/library/papers/39617485 | PubMed |
| 11 | 20671663 | Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). | MMWR Recomm Rep | 2010 | https://conductscience.org/library/papers/20671663 | PubMed |
| 12 | 24006295 | Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. | Am J Trop Med Hyg | 2013 | https://conductscience.org/library/papers/24006295 | PubMed |
| 13 | 25855494 | Long-lasting stem cell-like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/25855494 | PubMed |
| 14 | 25843268 | Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines? | Vaccine | 2015 | https://conductscience.org/library/papers/25843268 | PubMed |
| 15 | 28013052 | Yellow fever vaccination - Once in a lifetime? | Travel Med Infect Dis | 2017 | https://conductscience.org/library/papers/28013052 | PubMed |
| 16 | 19933869 | The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. | J Immunol | 2009 | https://conductscience.org/library/papers/19933869 | PubMed |
| 17 | 30476151 | Waning immunity after single-dose yellow fever vaccination: Who needs a second shot? | J Travel Med | 2019 | https://conductscience.org/library/papers/30476151 | PubMed |
| 18 | 23909008 | Vaccines and vaccination against yellow fever. WHO position paper -- June 2013. | Wkly Epidemiol Rec | 2013 | https://conductscience.org/library/papers/23909008 | PubMed |
| 19 | 32655896 | Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection. | NPJ Vaccines | 2020 | https://conductscience.org/library/papers/32655896 | PubMed |
| 20 | 17012867 | Yellow fever 17D vaccine safety and immunogenicity in the elderly. | Hum Vaccin | 2005 | https://conductscience.org/library/papers/17012867 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40733652
GET https://conductscience.org/api/papers/v1/40733652/references?page=2